Comprehensive characterization of KRAS mutations and inter-relation with primary tumor location in colorectal cancers.

Authors

Mohamed Salem

Mohamed E. Salem

Levine Cancer Institute, Charlotte, NC;

Mohamed E. Salem , Scott Kopetz , Josep Tabernero , Frank A. Sinicrope , Myriam Chalabi , Jeanne Tie , Kunal C. Kadakia , Thomas J. George , Elizabeth Mauer , Lisa Macera , Calvin Y. Chao , Sara Lonardi , Eric Van Cutsem , Thierry Andre , Michael J. Overman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 231)

DOI

10.1200/JCO.2023.41.4_suppl.231

Abstract #

231

Poster Bd #

M13

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Gastrointestinal Cancers Symposium

<span>Association of candidate alterations with primary resistance to </span><em>KRAS G12D </em><span>targeting in colorectal cancer.</span>

Association of candidate alterations with primary resistance to KRAS G12D targeting in colorectal cancer.

First Author: Khalid Jazieh

Poster

2022 ASCO Gastrointestinal Cancers Symposium

Genomic landscape of <em>ERBB2/3</em> alterations in colorectal cancer: Comutations, immuno-oncology biomarkers, and consensus molecular subtype.

Genomic landscape of ERBB2/3 alterations in colorectal cancer: Comutations, immuno-oncology biomarkers, and consensus molecular subtype.

First Author: Jeanne Tie

First Author: Mohamed E. Salem

Poster

2019 Gastrointestinal Cancers Symposium

A KRAS mutation is associated with an immunosuppressive tumor microenvironment in mismatch-repair proficient colorectal cancer.

A KRAS mutation is associated with an immunosuppressive tumor microenvironment in mismatch-repair proficient colorectal cancer.

First Author: Michael Marco